查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513650

矫正器市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2032

Orthotics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球矫正器市场的综合报告。该报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

重要见解

  • 矫正器市场规模（2024年）：48亿美元
  • 预计市值（2032 年）：88 亿美元
  • 全球市场成长率（2024-2032年复合年增长率）：7.8%

矫正器市场 - 研究范围：

矫正器在肌肉骨骼和神经肌肉疾病的管理和治疗中发挥重要作用，为身体提供支撑和调整。这些设备可治疗多种疾病，包括关节炎、糖尿病和术后恢復。矫正器市场在医院、诊所、矫正中心和家庭护理机构提供各种产品，包括矫正器、踝矫正器、膝矫正器和脊椎矫正器。肌肉骨骼疾病的盛行率不断上升、老年人口的增加以及提高患者舒适度和治疗效果的矫形技术的进步推动了市场成长。

市场驱动因素：

全球矫正器市场由几个关键因素推动，包括人们越来越认识到矫正器作为各种肌肉骨骼疾病的非侵入性治疗选择。糖尿病和肥胖症盛行率的上升以及足部和脚踝护理矫正器的需求不断增加，进一步推动了市场的扩张。技术进步，例如使用 3D 列印开发客製化矫正器和带有感测器的智慧矫正器，将改善患者的治疗效果并推动市场成长。此外，家庭矫正器解决方案的日益普及和远距医疗服务的扩展正在为市场参与者接触更多患者群体创造新的途径。

市场限制因素：

儘管成长前景广阔，但矫正器市场面临监管合规性、报销政策和高级矫正器高成本等课题。有关矫形器製造、销售和使用的严格法规给製造商和医疗保健提供者带来了合规负担，影响了市场进入障碍和营运成本。此外，矫正器治疗的报销范围有限以及客製化矫正器的高成本对市场渗透构成了课题，特别是在医疗保健预算有限的新兴经济体。解决这些监管和经济障碍需要行业利益相关者和政策制定者之间的合作，以促进获得安全且负担得起的矫形解决方案。

市场机会：

由于技术创新、人口趋势和不断发展的医疗保健服务模式，矫正器市场提供了巨大的成长机会。远端监控和远距医疗平台等数位健康技术的整合增加了患者获得矫正器服务的机会，并提高了治疗依从性和结果。此外，矫正器的应用范围不断扩大，超出了肌肉骨骼疾病的范围，例如神经系统疾病的治疗和康復，正在扩大市场范围并刺激创新。策略合作伙伴关係、研发投资以及推出用户友好且具有成本效益的矫形解决方案对于利用新机会并在动态矫形领域保持市场领先地位至关重要。

本报告解决的关键问题

  • 推动全球矫正器市场成长的关键因素是什么？
  • 哪些类型的矫正器和应用程式正在推动其在各种医疗保健环境中的采用？
  • 技术进步如何改变矫正器市场的竞争格局？
  • 谁是对矫正器市场做出贡献的主要公司？ 他们采取什么策略来维持市场地位？
  • 全球矫正器市场的新趋势和未来前景如何？

目录

第1章 内容提要

第2章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包容与排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第4章 关键成功因素

  • 监管状况
  • 消费者情绪分析
  • 市场公司的主要促销策略
  • PESTEL 分析
  • 波特的分析
  • 产品采用/使用分析
  • 供需分析
  • 冰山分析

第5章 市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第6章 COVID-19 危机分析

  • COVID-19 与影响分析
    • 依产品划分的收入
    • 依用户年龄组别划分的收入
    • 依使用情况划分的收入
    • 依材料划分的收入
    • 依用户划分的收入
    • 最终用户收入
    • 依地区划分的收入
  • 2024年市场情景

第7章 全球市场需求分析

  • 过去的市场价值分析，2019-2023
  • 当前和未来市场价值预测，2024-2032
    • 同比增长趋势分析
    • 绝对量机会分析

第 8 章世界市场分析：依产品分类

  • 简介/主要发现
  • 过去的市场规模分析：依产品分类，2019-2023
  • 目前和未来的市场规模分析和预测：依产品分类，2024-2032
    • 预製件
    • 订製
      • 刚性/功能性矫正鞋垫
      • 柔软/自适应鞋垫
  • 依产品划分的市场吸引力分析

第 9 章 全球市场分析：依使用者年龄组

  • 简介/主要发现
  • 过去的市场规模分析：依使用者年龄组别划分，2019-2023
  • 目前和未来的市场规模分析和预测：依使用者年龄组划分，2024-2032
    • 成人
    • 孩子
  • 依用户年龄组别划分的市场吸引力分析

第 10 章世界市场分析：依应用分类

  • 简介/主要发现
  • 过去的市场规模分析：依应用分类，2019-2023
  • 目前和未来的市场规模分析和预测：依应用分类，2024-2032
    • 体育运动
    • 医疗保健
    • 个人舒适度
  • 依应用划分的市场吸引力分析

第11章 世界市场分析：依材料分类

  • 简介/主要发现
  • 过去的市场规模分析：依材料分类，2019-2023
  • 目前和未来的市场规模分析和预测：依材料分类，2024-2032
    • 热塑性塑料
    • 聚乙烯泡沫
    • 皮革
    • 软木
    • 复合碳纤维
    • EVA
    • 凝胶
    • 其他
  • 依材料划分的市场吸引力分析

第十二章世界市场分析：依用户

  • 简介/主要发现
  • 过去的市场规模分析：依使用者划分，2019-2023
  • 目前和未来的市场规模分析和预测：依用户划分，2024-2032
    • 预製件
      • 成人
      • 孩子
    • 订製
      • 成人
      • 孩子
  • 用户市场吸引力分析

第十三章世界市场分析：依分销管道

  • 简介/主要发现
  • 过去的市场规模分析：依分销管道，2019-2023
  • 目前和未来的市场规模分析和预测：依分销管道，2024-2032
    • 药店
    • 医院和专科诊所
    • 网上商城
    • 其他
  • 依分销管道划分的市场吸引力分析

第14章 世界市场分析：依地区

  • 介绍
  • 历史市场规模分析：依地区划分，2019-2023
  • 目前和未来的市场规模分析和预测：依地区划分，2024-2032
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东/非洲
  • 依地区划分的市场吸引力分析

第15章 北美市场分析

第16章 拉丁美洲市场分析

第17章 欧洲市场分析

第18章 东亚市场分析

第19章 南亚市场分析

第20章 大洋洲市场分析

第21章 中东/非洲市场分析

第22章市场结构分析

  • 依公司层级进行市场分析
  • 主要参与者的市场占有率分析
  • 市场存在分析

第23章 竞争分析

  • 比赛仪表板
  • 衝突详情
    • Aetrex Worldwide Inc.
    • Bauerfeind AG
    • Acor Orthopedic
    • Amfit Inc.
    • Blatchford Clinical Services
    • Dr. Scholl's（Bayer）
    • Salts Techstep
    • The Foot Lab
    • Arden Orthotics Ltd.
    • Bolton Bros
    • Cascade Dafo Inc.
    • Algeo Limited
    • Tynor Orthotics Pvt. Ltd.
    • Ottobock, A. Algeo Ltd.
    • Hanger, Inc.
    • Bauerfeind AG
    • Birkenstock digital GmbH
    • Foot Science International
    • Groupe Gorge
    • DOLA-Digital Orthotics Laboratories Australia.
    • Fillauer LLC
    • Ossur Corporate
简介目录
Product Code: PMRREP33346

Persistence Market Research has recently released a comprehensive report on the worldwide market for orthotics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Orthotics Market Size (2024E): USD 4.8 Billion
  • Projected Market Value (2032F): USD 8.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 7.8%

Orthotics Market - Report Scope:

Orthotics play a crucial role in the management and treatment of musculoskeletal and neuromuscular disorders, providing support and alignment to the body. These devices cater to various medical conditions such as arthritis, diabetes, and post-operative recovery. The orthotics market serves hospitals, clinics, orthopedic centers, and homecare settings, offering a range of products including insoles, ankle braces, knee braces, and spinal orthoses. Market growth is driven by the increasing prevalence of musculoskeletal conditions, rising geriatric population, and advancements in orthotic technology, enhancing patient comfort and treatment outcomes.

Market Growth Drivers:

The global orthotics market is propelled by several key factors, including the growing awareness of orthotics as a non-invasive treatment option for various musculoskeletal conditions. The rising incidence of diabetes and obesity, leading to an increased need for orthotic devices for foot and ankle care, further drives market expansion. Technological advancements, such as the development of custom-made orthotic devices using 3D printing and smart orthotics with sensors, offer improved patient outcomes and promote market growth. Moreover, the increasing adoption of home-based orthotic solutions and the expansion of telemedicine services create new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the orthotics market faces challenges related to regulatory compliance, reimbursement policies, and the high cost of advanced orthotic devices. Stringent regulations governing the manufacturing, marketing, and use of orthotic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for orthotic treatments and the high cost of custom-made orthotic devices pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to safe and affordable orthotic solutions.

Market Opportunities:

The orthotics market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to orthotic services and improves treatment adherence and outcomes. Furthermore, the expanding application of orthotics beyond musculoskeletal conditions, including in the management of neurological disorders and rehabilitation, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective orthotic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic orthotics landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the orthotics market globally?
  • Which orthotic types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the orthotics market?
  • Who are the key players contributing to the orthotics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global orthotics market?

Competitive Intelligence and Business Strategy:

Leading players in the global orthotics market, including Ottobock, DJO Global, and Ossur, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced orthotic solutions, including custom-made devices and smart orthotics, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving orthotics landscape.

Key Companies Profiled:

  • Aetrex Worldwide Inc.
  • Bauerfeind AG
  • Acor Orthopedic
  • Amfit Inc.
  • Blatchford Clinical Services
  • Dr Scholl's (Bayer)
  • Salts Techstep
  • The Foot Lab
  • Arden Orthotics Ltd.
  • Bolton Bros
  • Cascade Dafo Inc.
  • Algeo Limited
  • Tynor Orthotics Pvt. Ltd.
  • Ottobock, A. Algeo Ltd.
  • Hanger, Inc.
  • Bauerfeind AG
  • Birkenstock digital GmbH
  • Foot Science International
  • Groupe Gorge
  • DOLA - Digital Orthotics Laboratories Australia.
  • Fillauer LLC,
  • Ossur Corporate
  • Basko Healthcare.
  • DJO Global

Orthotics Industry Research Segmentation

By Product:

  • Prefabricated
  • Custom

By User Age Group:

  • Adults
  • Paediatrics

By Application:

  • Sports & Athletics
  • Medical
  • Personal Comfort

By Material:

  • Thermoplastics
  • Polyethene Foams
  • Leather
  • Cork
  • Composite Carbon Fibers
  • EVA
  • Gel

By User:

  • Prefabricated
  • Custom

By Distribution Channel:

  • Drug Stores
  • Hospitals & Specialty Clinics
  • Online Stores

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Regulatory Landscape
  • 4.2. Consumer Sentiment Analysis
  • 4.3. Key Promotional Strategies, by Market Players
  • 4.4. PESTEL Analysis
  • 4.5. Porter's Analysis
  • 4.6. Product Adoption/Usage Analysis
  • 4.7. Demand Supply Analysis
  • 4.8. Iceberg Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Parent Market Analysis
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Surgery Volumes
    • 5.2.2. Rise in R&D Activities
    • 5.2.3. Rising Prevalence of Orthopedic Complications
    • 5.2.4. Increasing Incidence of Sports Injuries
    • 5.2.5. Growing Prevalence of Osteocarcinoma
    • 5.2.6. Historic Growth of Market players
    • 5.2.7. Rising Injuries Related to Adventure Sports
    • 5.2.8. Rising Prevalence of Arthritis
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Product
    • 6.1.2. Revenue By User Age Group
    • 6.1.3. Revenue By Application
    • 6.1.4. Revenue By Material
    • 6.1.5. Revenue By User
    • 6.1.6. Revenue By End User
    • 6.1.7. Revenue By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn ) Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Bn ) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn ) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn ) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Product, 2024-2032
    • 8.3.1. Prefabricated
    • 8.3.2. Custom
      • 8.3.2.1. Rigid/Function Orthotic Insoles
      • 8.3.2.2. Soft/ Accommodative Insoles
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2032, By User Age Group

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn ) Analysis By User Age Group, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By User Age Group, 2024-2032
    • 9.3.1. Adult
    • 9.3.2. Paediatric
  • 9.4. Market Attractiveness Analysis By User Age Group

10. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn ) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Application, 2024-2032
    • 10.3.1. Sports & Athletics
    • 10.3.2. Medical
    • 10.3.3. Personal Comfort
  • 10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Material

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn ) Analysis By Material, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Material, 2024-2032
    • 11.3.1. Thermoplastics
    • 11.3.2. Polyethylene Foams
    • 11.3.3. Leather
    • 11.3.4. Cork
    • 11.3.5. Composite Carbon Fibres
    • 11.3.6. EVA
    • 11.3.7. Gel
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis By Material

12. Global Market Analysis 2019-2023 and Forecast 2024-2032, By User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn ) Analysis By User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By User, 2024-2032
    • 12.3.1. Prefabricated
      • 12.3.1.1. Adult
      • 12.3.1.2. Pediatric
    • 12.3.2. Custom
      • 12.3.2.1. Adult
      • 12.3.2.2. Pediatric
  • 12.4. Market Attractiveness Analysis By User

13. Global Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Bn ) Analysis By Distribution Channel, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Distribution Channel, 2024-2032
    • 13.3.1. Drug Stores
    • 13.3.2. Hospitals & Specialty Clinics
    • 13.3.3. Online Stores
    • 13.3.4. Others
  • 13.4. Market Attractiveness Analysis By Distribution Channel

14. Global Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Region, 2024-2032
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. East Asia
    • 14.3.5. South Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Product
    • 15.3.3. By User Age Group
    • 15.3.4. By Application
    • 15.3.5. By Material
    • 15.3.6. By User
    • 15.3.7. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By User Age Group
    • 15.4.4. By Application
    • 15.4.5. By Material
    • 15.4.6. By User
    • 15.4.7. By Distribution Channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Market Trends
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. U.S. Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By User Age Group
        • 15.8.1.2.3. By Application
        • 15.8.1.2.4. By Material
        • 15.8.1.2.5. By User
        • 15.8.1.2.6. By Distribution Channel
    • 15.8.2. Canada Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By User Age Group
        • 15.8.2.2.3. By Application
        • 15.8.2.2.4. By Material
        • 15.8.2.2.5. By User
        • 15.8.2.2.6. By Distribution Channel

16. Latin America Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn ) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Mexico
      • 16.3.1.2. Brazil
      • 16.3.1.3. Argentina
      • 16.3.1.4. Rest of Latin America
    • 16.3.2. By Product
    • 16.3.3. By User Age Group
    • 16.3.4. By Application
    • 16.3.5. By Material
    • 16.3.6. By User
    • 16.3.7. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By User Age Group
    • 16.4.4. By Application
    • 16.4.5. By Material
    • 16.4.6. By User
    • 16.4.7. By Distribution Channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Market Trends
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Mexico Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By User Age Group
        • 16.8.1.2.3. By Application
        • 16.8.1.2.4. By Material
        • 16.8.1.2.5. By User
        • 16.8.1.2.6. By Distribution Channel
    • 16.8.2. Brazil Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By User Age Group
        • 16.8.2.2.3. By Application
        • 16.8.2.2.4. By Material
        • 16.8.2.2.5. By User
        • 16.8.2.2.6. By Distribution Channel
    • 16.8.3. Argentina Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By User Age Group
        • 16.8.3.2.3. By Application
        • 16.8.3.2.4. By Material
        • 16.8.3.2.5. By User
        • 16.8.3.2.6. By Distribution Channel

17. Europe Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. UK
      • 17.3.1.2. Germany
      • 17.3.1.3. Italy
      • 17.3.1.4. Italy.
      • 17.3.1.5. France
      • 17.3.1.6. Spain
      • 17.3.1.7. Russia
      • 17.3.1.8. BENELUX
      • 17.3.1.9. Rest of Europe
    • 17.3.2. By Product
    • 17.3.3. By User Age Group
    • 17.3.4. By Application
    • 17.3.5. By Material
    • 17.3.6. By User
    • 17.3.7. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By User Age Group
    • 17.4.4. By Application
    • 17.4.5. By Material
    • 17.4.6. By User
    • 17.4.7. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Market Trends
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. UK Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By User Age Group
        • 17.8.1.2.3. By Application
        • 17.8.1.2.4. By Material
        • 17.8.1.2.5. By User
        • 17.8.1.2.6. By Distribution Channel
    • 17.8.2. Germany Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By User Age Group
        • 17.8.2.2.3. By Application
        • 17.8.2.2.4. By Material
        • 17.8.2.2.5. By User
        • 17.8.2.2.6. By Distribution Channel
    • 17.8.3. Italy Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By User Age Group
        • 17.8.3.2.3. By Application
        • 17.8.3.2.4. By Material
        • 17.8.3.2.5. By User
        • 17.8.3.2.6. By Distribution Channel
    • 17.8.4. France Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By User Age Group
        • 17.8.4.2.3. By Application
        • 17.8.4.2.4. By Material
        • 17.8.4.2.5. By User
        • 17.8.4.2.6. By Distribution Channel
    • 17.8.5. Spain Market
      • 17.8.5.1. Introduction
      • 17.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.5.2.1. By Product
        • 17.8.5.2.2. By User Age Group
        • 17.8.5.2.3. By Application
        • 17.8.5.2.4. By Material
        • 17.8.5.2.5. By User
        • 17.8.5.2.6. By Distribution Channel
    • 17.8.6. Russia Market
      • 17.8.6.1. Introduction
      • 17.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.6.2.1. By Product
        • 17.8.6.2.2. By User Age Group
        • 17.8.6.2.3. By Application
        • 17.8.6.2.4. By Material
        • 17.8.6.2.5. By User
        • 17.8.6.2.6. By Distribution Channel
    • 17.8.7. BENELUX Market
      • 17.8.7.1. Introduction
      • 17.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.7.2.1. By Product
        • 17.8.7.2.2. By User Age Group
        • 17.8.7.2.3. By Application
        • 17.8.7.2.4. By Material
        • 17.8.7.2.5. By User
        • 17.8.7.2.6. By Distribution Channel

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By User Age Group
    • 18.3.4. By Application
    • 18.3.5. By Material
    • 18.3.6. By User
    • 18.3.7. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By User Age Group
    • 18.4.4. By Application
    • 18.4.5. By Material
    • 18.4.6. By User
    • 18.4.7. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By User Age Group
        • 18.8.1.2.3. By Application
        • 18.8.1.2.4. By Material
        • 18.8.1.2.5. By User
        • 18.8.1.2.6. By Distribution Channel
    • 18.8.2. Japan Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By User Age Group
        • 18.8.2.2.3. By Application
        • 18.8.2.2.4. By Material
        • 18.8.2.2.5. By User
        • 18.8.2.2.6. By Distribution Channel
    • 18.8.3. South Korea Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By User Age Group
        • 18.8.3.2.3. By Application
        • 18.8.3.2.4. By Material
        • 18.8.3.2.5. By User
        • 18.8.3.2.6. By Distribution Channel

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. India
      • 19.3.1.2. Thailand
      • 19.3.1.3. Indonesia
      • 19.3.1.4. Malaysia
      • 19.3.1.5. Rest of South Asia
    • 19.3.2. By Product
    • 19.3.3. By User Age Group
    • 19.3.4. By Application
    • 19.3.5. By Material
    • 19.3.6. By User
    • 19.3.7. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By User Age Group
    • 19.4.4. By Application
    • 19.4.5. By Material
    • 19.4.6. By User
    • 19.4.7. By Distribution Channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Market Trends
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. India Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By User Age Group
        • 19.8.1.2.3. By Application
        • 19.8.1.2.4. By Material
        • 19.8.1.2.5. By User
        • 19.8.1.2.6. By Distribution Channel
    • 19.8.2. Indonesia Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By User Age Group
        • 19.8.2.2.3. By Application
        • 19.8.2.2.4. By Material
        • 19.8.2.2.5. By User
        • 19.8.2.2.6. By Distribution Channel
    • 19.8.3. Malaysia Market
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By User Age Group
        • 19.8.3.2.3. By Application
        • 19.8.3.2.4. By Material
        • 19.8.3.2.5. By User
        • 19.8.3.2.6. By Distribution Channel
    • 19.8.4. Thailand Market
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By User Age Group
        • 19.8.4.2.3. By Application
        • 19.8.4.2.4. By Material
        • 19.8.4.2.5. By User
        • 19.8.4.2.6. By Distribution Channel

20. Oceania Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Product
    • 20.3.3. By User Age Group
    • 20.3.4. By Application
    • 20.3.5. By Material
    • 20.3.6. By User
    • 20.3.7. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By User Age Group
    • 20.4.4. By Application
    • 20.4.5. By Material
    • 20.4.6. By User
    • 20.4.7. By Distribution Channel
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Market Trends
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. Australia Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By User Age Group
        • 20.8.1.2.3. By Application
        • 20.8.1.2.4. By Material
        • 20.8.1.2.5. By User
        • 20.8.1.2.6. By Distribution Channel
    • 20.8.2. New Zealand Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By User Age Group
        • 20.8.2.2.3. By Application
        • 20.8.2.2.4. By Material
        • 20.8.2.2.5. By User
        • 20.8.2.2.6. By Distribution Channel

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2032

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Bn ) Analysis By Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Bn ) Analysis and Forecast By Market Taxonomy, 2024-2032
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. South Africa
      • 21.3.1.4. North Africa
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Product
    • 21.3.3. By User Age Group
    • 21.3.4. By Application
    • 21.3.5. By Material
    • 21.3.6. By User
    • 21.3.7. By Distribution Channel
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By User Age Group
    • 21.4.4. By Application
    • 21.4.5. By Material
    • 21.4.6. By User
    • 21.4.7. By Distribution Channel
  • 21.5. Key Market Participants - Intensity Mapping
  • 21.6. Drivers and Restraints - Impact Analysis
  • 21.7. Market Trends
  • 21.8. Country Level Analysis & Forecast
    • 21.8.1. GCC Countries Market
      • 21.8.1.1. Introduction
      • 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.1.2.1. By Product
        • 21.8.1.2.2. By User Age Group
        • 21.8.1.2.3. By Application
        • 21.8.1.2.4. By Material
        • 21.8.1.2.5. By User
        • 21.8.1.2.6. By Distribution Channel
    • 21.8.2. Turkey Market
      • 21.8.2.1. Introduction
      • 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.2.2.1. By Product
        • 21.8.2.2.2. By User Age Group
        • 21.8.2.2.3. By Application
        • 21.8.2.2.4. By Material
        • 21.8.2.2.5. By User
        • 21.8.2.2.6. By Distribution Channel
    • 21.8.3. South Africa Market
      • 21.8.3.1. Introduction
      • 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.3.2.1. By Product
        • 21.8.3.2.2. By User Age Group
        • 21.8.3.2.3. By Application
        • 21.8.3.2.4. By Material
        • 21.8.3.2.5. By User
        • 21.8.3.2.6. By Distribution Channel
    • 21.8.4. North Africa Market
      • 21.8.4.1. Introduction
      • 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.4.2.1. By Product
        • 21.8.4.2.2. By User Age Group
        • 21.8.4.2.3. By Application
        • 21.8.4.2.4. By Material
        • 21.8.4.2.5. By User
        • 21.8.4.2.6. By Distribution Channel

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. Regional footprint of Players
    • 22.3.2. Platform Type foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Deep Dive
    • 23.2.1. Aetrex Worldwide Inc.
      • 23.2.1.1. Overview & Key financials
      • 23.2.1.2. R& D Expenditure
      • 23.2.1.3. Sales Footprint
      • 23.2.1.4. Key Financial
      • 23.2.1.5. Key Development
      • 23.2.1.6. Strategy Overview
        • 23.2.1.6.1. Marketing Strategy
        • 23.2.1.6.2. Drug Strategy
        • 23.2.1.6.3. Channel Strategy
    • 23.2.2. Bauerfeind AG
      • 23.2.2.1. Overview & Key financials
      • 23.2.2.2. R& D Expenditure
      • 23.2.2.3. Sales Footprint
      • 23.2.2.4. Key Financial
      • 23.2.2.5. Key Development
      • 23.2.2.6. Strategy Overview
        • 23.2.2.6.1. Marketing Strategy
        • 23.2.2.6.2. Drug Strategy
        • 23.2.2.6.3. Channel Strategy
    • 23.2.3. Acor Orthopedic
      • 23.2.3.1. Overview & Key financials
      • 23.2.3.2. R& D Expenditure
      • 23.2.3.3. Sales Footprint
      • 23.2.3.4. Key Financial
      • 23.2.3.5. Key Development
      • 23.2.3.6. Strategy Overview
        • 23.2.3.6.1. Marketing Strategy
        • 23.2.3.6.2. Drug Strategy
        • 23.2.3.6.3. Channel Strategy
    • 23.2.4. Amfit Inc.
      • 23.2.4.1. Overview & Key financials
      • 23.2.4.2. R& D Expenditure
      • 23.2.4.3. Sales Footprint
      • 23.2.4.4. Key Financial
      • 23.2.4.5. Key Development
      • 23.2.4.6. Strategy Overview
        • 23.2.4.6.1. Marketing Strategy
        • 23.2.4.6.2. Drug Strategy
        • 23.2.4.6.3. Channel Strategy
    • 23.2.5. Blatchford Clinical Services
      • 23.2.5.1. Overview & Key financials
      • 23.2.5.2. R& D Expenditure
      • 23.2.5.3. Sales Footprint
      • 23.2.5.4. Key Financial
      • 23.2.5.5. Key Development
      • 23.2.5.6. Strategy Overview
        • 23.2.5.6.1. Marketing Strategy
        • 23.2.5.6.2. Drug Strategy
        • 23.2.5.6.3. Channel Strategy
    • 23.2.6. Dr. Scholl's (Bayer)
      • 23.2.6.1. Overview & Key financials
      • 23.2.6.2. R& D Expenditure
      • 23.2.6.3. Sales Footprint
      • 23.2.6.4. Key Financial
      • 23.2.6.5. Key Development
      • 23.2.6.6. Strategy Overview
        • 23.2.6.6.1. Marketing Strategy
        • 23.2.6.6.2. Drug Strategy
        • 23.2.6.6.3. Channel Strategy
    • 23.2.7. Salts Techstep
      • 23.2.7.1. Overview & Key financials
      • 23.2.7.2. R& D Expenditure
      • 23.2.7.3. Sales Footprint
      • 23.2.7.4. Key Financial
      • 23.2.7.5. Key Development
      • 23.2.7.6. Strategy Overview
        • 23.2.7.6.1. Marketing Strategy
        • 23.2.7.6.2. Drug Strategy
        • 23.2.7.6.3. Channel Strategy
    • 23.2.8. The Foot Lab
      • 23.2.8.1. Overview & Key financials
      • 23.2.8.2. R& D Expenditure
      • 23.2.8.3. Sales Footprint
      • 23.2.8.4. Key Financial
      • 23.2.8.5. Key Development
      • 23.2.8.6. Strategy Overview
        • 23.2.8.6.1. Marketing Strategy
        • 23.2.8.6.2. Drug Strategy
        • 23.2.8.6.3. Channel Strategy
    • 23.2.9. Arden Orthotics Ltd.
      • 23.2.9.1. Overview & Key financials
      • 23.2.9.2. R& D Expenditure
      • 23.2.9.3. Sales Footprint
      • 23.2.9.4. Key Financial
      • 23.2.9.5. Key Development
      • 23.2.9.6. Strategy Overview
        • 23.2.9.6.1. Marketing Strategy
        • 23.2.9.6.2. Drug Strategy
        • 23.2.9.6.3. Channel Strategy
    • 23.2.10. Bolton Bros
      • 23.2.10.1. Overview & Key financials
      • 23.2.10.2. R& D Expenditure
      • 23.2.10.3. Sales Footprint
      • 23.2.10.4. Key Financial
      • 23.2.10.5. Key Development
      • 23.2.10.6. Strategy Overview
        • 23.2.10.6.1. Marketing Strategy
        • 23.2.10.6.2. Drug Strategy
        • 23.2.10.6.3. Channel Strategy
    • 23.2.11. Cascade Dafo Inc.
      • 23.2.11.1. Overview & Key financials
      • 23.2.11.2. R& D Expenditure
      • 23.2.11.3. Sales Footprint
      • 23.2.11.4. Key Financial
      • 23.2.11.5. Key Development
      • 23.2.11.6. Strategy Overview
        • 23.2.11.6.1. Marketing Strategy
        • 23.2.11.6.2. Drug Strategy
        • 23.2.11.6.3. Channel Strategy
    • 23.2.12. Algeo Limited
      • 23.2.12.1. Overview & Key financials
      • 23.2.12.2. R& D Expenditure
      • 23.2.12.3. Sales Footprint
      • 23.2.12.4. Key Financial
      • 23.2.12.5. Key Development
      • 23.2.12.6. Strategy Overview
        • 23.2.12.6.1. Marketing Strategy
        • 23.2.12.6.2. Drug Strategy
        • 23.2.12.6.3. Channel Strategy
    • 23.2.13. Tynor Orthotics Pvt. Ltd.
      • 23.2.13.1. Overview & Key financials
      • 23.2.13.2. R& D Expenditure
      • 23.2.13.3. Sales Footprint
      • 23.2.13.4. Key Financial
      • 23.2.13.5. Key Development
      • 23.2.13.6. Strategy Overview
        • 23.2.13.6.1. Marketing Strategy
        • 23.2.13.6.2. Drug Strategy
        • 23.2.13.6.3. Channel Strategy
    • 23.2.14. Ottobock, A. Algeo Ltd.
      • 23.2.14.1. Overview & Key financials
      • 23.2.14.2. R& D Expenditure
      • 23.2.14.3. Sales Footprint
      • 23.2.14.4. Key Financial
      • 23.2.14.5. Key Development
      • 23.2.14.6. Strategy Overview
        • 23.2.14.6.1. Marketing Strategy
        • 23.2.14.6.2. Drug Strategy
        • 23.2.14.6.3. Channel Strategy
    • 23.2.15. Hanger, Inc.
      • 23.2.15.1. Overview & Key financials
      • 23.2.15.2. R& D Expenditure
      • 23.2.15.3. Sales Footprint
      • 23.2.15.4. Key Financial
      • 23.2.15.5. Key Development
      • 23.2.15.6. Strategy Overview
        • 23.2.15.6.1. Marketing Strategy
        • 23.2.15.6.2. Drug Strategy
        • 23.2.15.6.3. Channel Strategy
    • 23.2.16. Bauerfeind AG
      • 23.2.16.1. Overview & Key financials
      • 23.2.16.2. R& D Expenditure
      • 23.2.16.3. Sales Footprint
      • 23.2.16.4. Key Financial
      • 23.2.16.5. Key Development
      • 23.2.16.6. Strategy Overview
        • 23.2.16.6.1. Marketing Strategy
        • 23.2.16.6.2. Drug Strategy
        • 23.2.16.6.3. Channel Strategy
    • 23.2.17. Birkenstock digital GmbH
      • 23.2.17.1. Overview & Key financials
      • 23.2.17.2. R& D Expenditure
      • 23.2.17.3. Sales Footprint
      • 23.2.17.4. Key Financial
      • 23.2.17.5. Key Development
      • 23.2.17.6. Strategy Overview
        • 23.2.17.6.1. Marketing Strategy
        • 23.2.17.6.2. Drug Strategy
        • 23.2.17.6.3. Channel Strategy
    • 23.2.18. Foot Science International
      • 23.2.18.1. Overview & Key financials
      • 23.2.18.2. R& D Expenditure
      • 23.2.18.3. Sales Footprint
      • 23.2.18.4. Key Financial
      • 23.2.18.5. Key Development
      • 23.2.18.6. Strategy Overview
        • 23.2.18.6.1. Marketing Strategy
        • 23.2.18.6.2. Drug Strategy
        • 23.2.18.6.3. Channel Strategy
    • 23.2.19. Groupe Gorge
      • 23.2.19.1. Overview & Key financials
      • 23.2.19.2. R& D Expenditure
      • 23.2.19.3. Sales Footprint
      • 23.2.19.4. Key Financial
      • 23.2.19.5. Key Development
      • 23.2.19.6. Strategy Overview
        • 23.2.19.6.1. Marketing Strategy
        • 23.2.19.6.2. Drug Strategy
        • 23.2.19.6.3. Channel Strategy
    • 23.2.20. DOLA - Digital Orthotics Laboratories Australia.
      • 23.2.20.1. Overview & Key financials
      • 23.2.20.2. R& D Expenditure
      • 23.2.20.3. Sales Footprint
      • 23.2.20.4. Key Financial
      • 23.2.20.5. Key Development
      • 23.2.20.6. Strategy Overview
        • 23.2.20.6.1. Marketing Strategy
        • 23.2.20.6.2. Drug Strategy
        • 23.2.20.6.3. Channel Strategy
    • 23.2.21. Fillauer LLC
      • 23.2.21.1. Overview & Key financials
      • 23.2.21.2. R& D Expenditure
      • 23.2.21.3. Sales Footprint
      • 23.2.21.4. Key Financial
      • 23.2.21.5. Key Development
      • 23.2.21.6. Strategy Overview
        • 23.2.21.6.1. Marketing Strategy
        • 23.2.21.6.2. Drug Strategy
        • 23.2.21.6.3. Channel Strategy
    • 23.2.22. Ossur Corporate
      • 23.2.22.1. Overview & Key financials
      • 23.2.22.2. R& D Expenditure
      • 23.2.22.3. Sales Footprint
      • 23.2.22.4. Key Financial
      • 23.2.22.5. Key Development
      • 23.2.22.6. Strategy Overview
        • 23.2.22.6.1. Marketi